Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.42), $0.04 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $3.46 million versus the consensus estimate of $3.05 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.